Table 2

 Differences between women and men with gout in diagnostic evaluation and surveillance during the period under study

TestMenWomenUnadjustedAdjusted*
n%n%OR (95% CI)OR (95% CI)
*Adjusted for age, number of encounters with a gout diagnosis, gout-associated comorbidities (including hypertension, dyslipidaemia, coronary heart disease, peripheral arterial disease, diabetes mellitus, nephrolithiasis, renal insufficiency and renal failure), use of diuretics and health plan.
Serum urate332767795691.09 (0.95 to 1.25)1.20 (1.02 to 1.40
24-h urine for uric acid excretion24556761.19 (0.90 to 1.57)1.40 (1.04 to 1.90)
Synovial fluid cell count22653430.64 (0.44 to 0.92)0.56 (0.38 to 0.83)
Synovial crystal analysis24553220.56 (0.38 to 0.80)0.49 (0.34 to 0.72)
Diagnostic aspirations or therapeutic joint or bursal injections77115217191.26 (1.07 to 1.49)1.10 (0.91 to 1.32)